Thanks Tryz, SCRC is only jumping a hurdle right now but like I said, Mr. Schneiderman's brilliant strategies are right in line with what needs to be done to maintain and grow SCRC's revenues and profitability. My prediction, none of use with recognize SCRC in six months. Diversifying like Mr. Schneiderman is doing is turning SCRC into a multi-faceted business enterprise. I can't wait to learn more about the physician dispensing program mentioned in the last PR. Having been in the pharma industry for over 37 years, this one venture has the potential to be SCRC's cash cow as we say in the industry. I love what I see right now. My confidence in SCRC couldn't be higher.